The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 25, 2014

Filed:

Feb. 27, 2009
Applicants:

Mariko Morishita, Tokyo, JP;

Kozo Takayama, Tokyo, JP;

Reiji Nishio, Kamakura, JP;

Nobuo Ida, Kamakura, JP;

Inventors:

Mariko Morishita, Tokyo, JP;

Kozo Takayama, Tokyo, JP;

Reiji Nishio, Kamakura, JP;

Nobuo Ida, Kamakura, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/19 (2006.01); A61K 38/28 (2006.01); A61K 38/00 (2006.01); A61K 38/21 (2006.01); C07K 14/435 (2006.01); A61K 38/10 (2006.01); A61K 9/00 (2006.01); A61K 47/42 (2006.01);
U.S. Cl.
CPC ...
A61K 38/215 (2013.01); A61K 38/28 (2013.01); C07K 14/43581 (2013.01); A61K 38/10 (2013.01); A61K 9/0043 (2013.01); A61K 47/42 (2013.01);
Abstract

A method for nasal administration of a pharmaceutical composition comprising a hydrophilic bioactive substance and any one of (a) to (c): (a) a peptide having the amino acid sequence shown in SEQ ID NO:1; (b) a peptide having the same amino acid sequence as shown in SEQ ID NO:1 except that one or several amino acids are deleted, substituted and/or added, the peptide having nasal mucosal permeability; (c) a peptide having an amino acid sequence represented by the reverse sequence of (a) or (b), the peptide having nasal mucosal permeability, with the proviso that a C-terminal amidated peptide is excluded. A hydrophilic bioactive substance having a low transmucosal absorption capability which has conventionally been able to be administered by only injection can be nasally administered. Such a pharmaceutical composition is useful for improvement of the pain and the inconvenience of patients caused by administration by injection.


Find Patent Forward Citations

Loading…